Evaluation of Novel Biomarkers to Improve Risk Stratification and Patient Selection in Implantable Cardioverter-defibrillator (ICD) Therapy

NCT01594073 · clinicaltrials.gov ↗
COMPLETED
Status
500
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Hannover Medical School